18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: A Pilot Study
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the usefulness of PET/MRI with an investigational
radioactive drug, 18F-rhPSMA-7.3, and MRI contrast in evaluating patients with prostate
cancer eligible for active surveillance. This study is for imaging purposes only and is not a
treatment study.